Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: kathyh who wrote (18316)	3/18/1999 10:02:00 PM
From: Tim Luke	Respond to of 90042

kathy, my thoughts on eggs is .."i would love to short this dog all the way down to 10$ where it belongs

To: kathyh who wrote (18316)	3/18/1999 10:07:00 PM
From: Tim Luke	Read Replies (1) \| Respond to of 90042

((>>COO>>)) here is a stock that has been on my trading lost since it was 3$...looks like i will buy in tomorrow. ; ; ; ;; Cooper may be a takeover candidate - report NEW YORK, March 18 (Reuters) - Cooper Cos, having recently shed its Hospital Group of America unit, may be a takeover target for larger lensmakers such as Johnson & Johnson (NYSE:JNJ - news) or Bausch & Lomb (NYSE:BOL - news), according to an article in Businessweek. The report suggests that the company, which has fallen to 14 on the NYSE from as high as 28 in November due to price pressures in its contact-lens business, is vulnerable to acquisition because of its deflated stock price. Cooper derives nearly 50 percent of its revenues from its Cooper-Vision unit, which produces a soft contact-lens that corrects astigmatism. Cooper's other unit, CooperSurgical, makes medical devices for women's health care.